Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10

FDA recall notice · announced October 12, 2016 · Shire

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10

Reason for recall

Presence of Foreign Tablets/Capsules

Notes

Distribution: Nationwide
Lot/code information: Lot # AF3360B; Exp. 04/19
Quantity: 7,680 bottles (768,000 capsules)
Status: Terminated
Products in this recall event:
- Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10 (D-0006-2017)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.